Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 244.45
-1.60 (-0.65%)
At close: Sep 25, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 106.69 billion as of September 25, 2026. Its market cap has increased by 114.86% in one year.
Market Cap
106.69B
Enterprise Value
111.03B
Revenue
35.75B
Ranking
n/a
PE Ratio
51.49
Stock Price
244.45
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 106.69B, an increase of 30,581.06%. That is a compound annual growth rate of 30.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 106.69B | 17.64% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caplin Point Laboratories | 217.83B |
| Granules India | 211.49B |
| Jubilant Pharmova | 168.44B |
| AstraZeneca Pharma India | 164.72B |
| Procter & Gamble Health | 90.03B |
| Bliss GVS Pharma | 72.89B |
| Sanofi India | 72.43B |
| Morepen Laboratories | 63.92B |